Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Retatrutide for Sale > Factory Direct Supply Retatrutide Raw Powder CAS 2381089-83-2 Peptide API Bulk Raw Powder Pharmaceutical Grade Peptide Raw Material
Factory Direct Supply Retatrutide Raw Powder CAS 2381089-83-2 Peptide API Bulk Raw Powder Pharmaceutical Grade Peptide Raw Material buy - large image1
Factory Direct Supply Retatrutide Raw Powder CAS 2381089-83-2 Peptide API Bulk Raw Powder Pharmaceutical Grade Peptide Raw Material buy - image1
Factory Direct Supply Retatrutide Raw Powder CAS 2381089-83-2 Peptide API Bulk Raw Powder Pharmaceutical Grade Peptide Raw Material buy - image2
Factory Direct Supply Retatrutide Raw Powder CAS 2381089-83-2 Peptide API Bulk Raw Powder Pharmaceutical Grade Peptide Raw Material buy - image3
Factory Direct Supply Retatrutide Raw Powder CAS 2381089-83-2 Peptide API Bulk Raw Powder Pharmaceutical Grade Peptide Raw Material buy - image4
Factory Direct Supply Retatrutide Raw Powder CAS 2381089-83-2 Peptide API Bulk Raw Powder Pharmaceutical Grade Peptide Raw Material buy - image5
Factory Direct Supply Retatrutide Raw Powder CAS 2381089-83-2 Peptide API Bulk Raw Powder Pharmaceutical Grade Peptide Raw Material buy - image6

Factory Direct Supply Retatrutide Raw Powder CAS 2381089-83-2 Peptide API Bulk Raw Powder Pharmaceutical Grade Peptide Raw Material

TDS 7503 Inquiries

Unit Price:

$139/G FOB

Get Latest Price
CAS No.:

2381089-83-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Guangzhou

Brand:

EnShi

Packaging:

1G

Sample Available:

Yes

Price valid (until):

2029-01-01

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
3 days
Qualification:
Main Products:

peptides

  • Product Details

  • Seller Information

  • Inquiry History

  • Description

       Name :Leona

    Whatsapp/wechat:+86 13653332300

    Email:sjzes4@enshikj.com

    What is Retatrutide ?                                                   

    Retatrutide belongs to a class of drugs known as multi-receptor agonists, used to treat obesity and underlying type 2 diabetes. It specifically targets GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic peptide), and sometimes the glucagon receptor. These hormones naturally regulate appetite, insulin secretion, and metabolism.  In short, retatrutide is a next-generation “triple hormone” therapy designed to tackle obesity and metabolic disorders more effectively than older drugs.

    • Shop Factory Direct Supply Retatrutide Raw Powder CAS 2381089-83-2 Peptide API Bulk Raw Powder Pharmaceutical Grade Peptide Raw Material-Detailed Image 1
    • Retatrutide Benefits:                                                   

      1.Powerful metabolic regulation
      Supports healthy glucose and lipid metabolism.

    • 2.Healthy body composition
      Helps maintain ideal weight and reduce excess fat.

    • 3.Improved insulin sensitivity
      Promotes stable blood sugar levels.

    • 4.Enhanced energy metabolism
      Reduces fatigue and boosts physical vitality.

    • 5.Appetite management support
      Helps control cravings and promote satiety.

    • 6.High purity & well-tolerated
      Safe for long-term metabolic health support.

    • Shop Factory Direct Supply Retatrutide Raw Powder CAS 2381089-83-2 Peptide API Bulk Raw Powder Pharmaceutical Grade Peptide Raw Material-Detailed Image 2

      Therapeutic Applications:                                           

      1、Primary Indications:

    • Chronic weight management in adults with obesity (BMI ≥30 kg/m²) or overweight (BMI ≥27 kg/m²) with at least one weight-related comorbidity

    • Glycemic control in adults with type 2 diabetes mellitus

    • 2、Potential Off-Label Uses:

    • Non-alcoholic steatohepatitis (NASH), polycystic ovary syndrome (PCOS), and metabolic syndrome (under clinical investigation)

    • Shop Factory Direct Supply Retatrutide Raw Powder CAS 2381089-83-2 Peptide API Bulk Raw Powder Pharmaceutical Grade Peptide Raw Material-Detailed Image 3

    Safety & Tolerability Profile:                                    

    1、Most Common Adverse Events: Mild-to-moderate gastrointestinal symptoms (nausea, diarrhea, constipation), typically transient and resolving with dose titration
    2、Contraindications: History of pancreatitis, severe gastrointestinal disease, or hypersensitivity to the peptide
    3、Special Populations: Caution in patients with renal impairment; not recommended during pregnancy/lactation

    Shop Factory Direct Supply Retatrutide Raw Powder CAS 2381089-83-2 Peptide API Bulk Raw Powder Pharmaceutical Grade Peptide Raw Material-Detailed Image 4

    • Product Specification:                                                 

    • Items Specifications
      Product Name Retatrutide
      CAS No. 2381089-83-2
      Purity >99.0%
      Molecular Formula C₂₂₁H₃₄₂N₄₆O₆₈
      Molecular Weight 4731.33-4731.42 Da (free base)
      Synonyms LY3437943, GGG Tri-agonist, Synthetic peptide agonist (GLP-1/GIP/Glucagon triple agonist)
      Storage -20°C or below, keep away from light, moisture and heat.
      Shop Factory Direct Supply Retatrutide Raw Powder CAS 2381089-83-2 Peptide API Bulk Raw Powder Pharmaceutical Grade Peptide Raw Material-Detailed Image 5
    • Company Profile:                                                       

    Enshi Technology Co., Ltd is a modern advanced enterprise specializing in production and exportation of APIs, Pharmaceutical intermediates, plant extracts etc. Our products are widely used in medicine, health care products, cosmetics, nutritional supplements and food additives areas. With years of experience in the pharmaceutical chemical and biosynthetic industries.It provides compliant, stable and cost-effective core raw materials as well as one-stop CDMO/CMO solutions for global pharmaceutical enterprises and innovative drug R&D institutions.

    Shop Factory Direct Supply Retatrutide Raw Powder CAS 2381089-83-2 Peptide API Bulk Raw Powder Pharmaceutical Grade Peptide Raw Material-Detailed Image 6 Shop Factory Direct Supply Retatrutide Raw Powder CAS 2381089-83-2 Peptide API Bulk Raw Powder Pharmaceutical Grade Peptide Raw Material-Detailed Image 7 Shop Factory Direct Supply Retatrutide Raw Powder CAS 2381089-83-2 Peptide API Bulk Raw Powder Pharmaceutical Grade Peptide Raw Material-Detailed Image 8

    Packing:                                                                       

    Shop Factory Direct Supply Retatrutide Raw Powder CAS 2381089-83-2 Peptide API Bulk Raw Powder Pharmaceutical Grade Peptide Raw Material-Detailed Image 9

    Shipping:                                                                    

    Shop Factory Direct Supply Retatrutide Raw Powder CAS 2381089-83-2 Peptide API Bulk Raw Powder Pharmaceutical Grade Peptide Raw Material-Detailed Image 10

    FAQ:                                                                            

    1. How to make an order?
    Send me message and let me know what you need with quantity , then i will calculate to you

    2. What's the lead time and shipping ways?
    We will delivery to the package by USPS, FEDEX, DHL paket and YANWEN express to you after receive your payment, it would take around 5-15 days to your address.

    3. How do i keep the peptides when i receive it ?
    Peptides in the form of lyophilized powder can be transported at room temperature by vacuum packaging, while polypeptides in the dissolved state need to be refrigerated at 2°C - 8°C. For long-term storage, peptides should be stored in the form of lyophilized powder store at -20°C or -80°C in a sealed container with desiccant, which can avoid the degradation of peptides to the greatest extent.

    4. What's the payment methods ?
    We could accept pay through paypal,bank transfer, XTransfer and bitcoin.

    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.
    Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.

    Certificates

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    InChIKeys:

    MLOLQJNKXBNWFW-SAGGEDDASA-N

    Molecular Weight:

    0

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    peptides

    Location:

    Room 704#-A010, Building 11, Block 16, Liangzhu Street, Yuhang District, Hangzhou City, Zhejiang Province

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    3 days

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    5-10

    Year of Establishment:

    2025

    Company Certificates
    • Enshi Technology Co., Ltd.Examining report Examining report

    Our company is a modern advanced enterprise specializing in production and exportation of APIs, Pharmaceutical intermediates, plant extracts etc. Our products are widely used in medicine, health care products, cosmetics, nutritional supplements and food additives areas. Our factory covers an area of 95 acres, the proposed construction of the plant will be GMP standards, the factory environment clean and tidy, rational layout, with large and medium-sized production workshop and repocessed shop. It is equipped with advanced equipment quality inspection and research center. Those products of both quality and technical content have reached the domestic advanced level. Since its establishment, the company has attached great importance to the team training and technical reform. Our modern production equipment guarantees for a fast and effective production with a superior degree of accuracy throughout the whole production line, everything is done in-house, processing, extraction, packaging and transportation of all links, ensuring maximum quality and efficiency. We are constantly research and development new ingredients and innovative new products, have earned the respect & Admiration from the worldwide customers. After years of continuous development, company has been accumulated rich experience in international trade and customer resources, established a stable customer base and perfect marketing service network. In addition, the company has established long-term technical cooperation with experts and professors from many universities and research institutes in the province.

  • Inquiry History
    7503 Inquiries
    Country Product Purchase Quantity Date Posted
    Malaysia

    Retatrutide

    20 MG Oct 28, 2026
    Australia

    Retaturtide

    100 MG Oct 29, 2026
    United States

    Retatrutide 30mg and 50mg

    20 PCS Oct 29, 2026
    Belgium

    Retatrutide

    1 MG Oct 29, 2026
    Romania

    Retatrutide

    10 G Oct 29, 2026
    United States

    Retatrutide

    2 MT Oct 29, 2026
    United States

    Retatrutide

    1 MT Oct 29, 2026
    United Kingdom

    Retatrutide

    1 PCS Oct 28, 2026
    United States

    Retatrutide

    30 MT Oct 28, 2026
    United Kingdom

    Retatrutide

    10 MT Oct 28, 2026
    United States

    retatrutide

    30 MG Oct 28, 2026
    Czech

    Retatrutide

    10 MG Oct 28, 2026
    Austria

    retatrutide

    30 MG Oct 28, 2026
    United States

    Retatrutide

    100 KG Oct 28, 2026
    Malta

    Retatrutide

    10 MT Oct 28, 2026
    United States

    Retatrutide

    600 MG Oct 28, 2026
    United States

    Retatrutide

    500 G Oct 28, 2026
    United States

    Retatrutide

    60 G Oct 28, 2026
    Croatia

    Retatrutide

    10 MG Oct 28, 2026
    United States

    Retatrutide

    200 MG Oct 28, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.